Speakers


Patrick Tabeling
Patrick Tabeling

Director of the IPGG and research Director at CNRS, Patrick Tabeling is a french physicist, microfluidics pioneer in France, professor at the École supérieure de physique et de chimie industrielle de la ville de Paris (ESPCI Paris). He has published more than 181 articles in prestigious peer reviewed journals and his work has been cited more than 7000 times.

Jérôme Bibette
Jérôme Bibette

He is the Professor of Soft Matter Physics at École Supérieure de Chimie Industrielles de Paris (ESPCI) and the co-director of the Michelin Advanced Research Initiative at ESPCI. Jérôme received his PhD in Physical Chemistry from the University of Bordeaux in 1990, and went on to become a Professor at the University, where his work in the areas of emulsions, colloid chemistry, complex fluids and soft condensed matter physics led to the award of the CNRS Silver Medal. He then became a Professor at ESPCI in 2001. Jérôme is also a co-founder of Ademtech, Raindance Technologies, Capsum, HiFi-Bio, BioMillenia and MilliDrop Instruments.

Klavs-f-jensen
Klavs F. Jensen

Klavs F. Jensen is Warren K. Lewis Professor in Chemical Engineering and Materials Science and Engineering at the Massachusetts Institute of Technology. From 2007 to July 2015 he was the Head of the Department of Chemical Engineering. He received his Ph.D. in chemical engineering from the University of Wisconsin-Madison. His research interests revolve around reaction and separation techniques for on-demand multistep synthesis, as well as microsystems biological discovery and manipulation. Catalysis, chemical kinetics and transport phenomena are also topics of interest along with development of simulation approaches for reactive chemical and biological systems. He chairs the Editorial Board for the new Royal Society of Chemistry Journal Reaction Chemistry and Engineering. He serves on advisory boards to universities, companies, professional societies, and governments. Professor Jensen is a member of the US National Academy of Engineering and the American Academy of Arts and Science. He is a Fellow of the American Association for the Advancement of Science (AAAS), the American Chemical Society, and the American Institute of Chemical Engineers, and the Royal.

Andrew Griffihs
Andrew Griffihs

Andrew Griffiths is a Professor of Biochemistry at École Supérieure de Chimie Industrielles de Paris (ESPCI Paris) in Paris and formerly the holder of a Chaire d’Excellence from the Ministère pour la Recherche, France, at the Institut de Science et d’Ingénierie Supramoléculaires (ISIS) in Strasbourg. After receiving a B.Sc. in Biochemistry (First Class) from the University of Sheffield in 1985 and a Ph.D. from the University of Leicester, in 1988, he joined Greg Winter at the MRC Laboratory of Molecular Biology (LMB), Cambridge where he co-developed phage-display for the selection of human antibodies for therapy, first as a Post Doc. (1989-1990) and later as a Cancer Research Campaign Fellow (1991-1995). This work led directly to the creation of two companies, Cambridge Antibody Technology and Domantis, and several blockbuster drugs including Humira® and Benlysta®. His current work is in the development of droplet-based microfluidic systems for directed evolution of enzymes, high-throuhgput screening for drug discovery, and diagnostic applications. Andrew is a founder of RainDance Technologies.